reports
Infragreen Group Ltd: 3 directors
Three Directors at Infragreen Group Ltd bought 833,800 shares at between 0.355AUD and 0.390AUD. The significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors o...
Press Release: Sanofi’s rilzabrutinib earns orphan drug designation in...
Press Release: Sanofi’s rilzabrutinib earns orphan drug designation in Japan for IgG4-related disease Sanofi’s rilzabrutinib earns orphan drug designation in Japan for IgG4-related disease Designation based on positive data from a phase 2 study of rilzabrutinib in IgG4-RDThird global orphan drug designation for rilzabrutinib in IgG4-RD, underpinning Sanofi’s commitment to rare immune-mediated diseases Paris, March 2, 2026 – The Ministry of Health, Labour and Welfare (MHLW) in Japan has granted orphan drug designation to rilzabrutinib, a novel, oral, reversible covalent Bruton’s tyrosine ...
Communiqué de presse : Le rilzabrutinib de Sanofi obtient la désignati...
Communiqué de presse : Le rilzabrutinib de Sanofi obtient la désignation de médicament orphelin au Japon pour la maladie liée aux IgG4 Le rilzabrutinib de Sanofi obtient la désignation de médicament orphelin au Japon pour la maladie liée aux IgG4 La désignation s’appuie sur les données positives d’une étude de phase 2 sur le rilzabrutinib dans la maladie liée aux IgG4Il s’agit de la troisième désignation mondiale de médicament orphelin pour le rilzabrutinib dans le traitement de la maladie liée aux IgG4, soulignant l’engagement de Sanofi dans la lutte contre les maladies rares à médiation...
Space42 and Viasat to Share Progress on Equatys at Mobile World Congre...
Space42 and Viasat to Share Progress on Equatys at Mobile World Congress Companies advance plans for global system architecture and shared infrastructure for Direct-to-Device and other Advanced Mobile Satellite Services BARCELONA, Spain, March 02, 2026 (GLOBE NEWSWIRE) -- , the UAE-based AI-powered SpaceTech company, and , a global leader in satellite communications, will discuss continued progress toward their planned direct-to-device (D2D) infrastructure and offer an early look at the priorities for Equatys, the companies' forthcoming joint entity, during a co-hosted program at Mobile...
- Stijn Demeester
Aktsiaselts Infortar own share acquisition transactions
Aktsiaselts Infortar own share acquisition transactions Aktsiaselts Infortar acquired its own shares on the Nasdaq Tallinn Stock Exchange during the period of 23 - 27 February 2026 as follows: DateAggregated volume (pcs)Weighted average price per day (EUR)23.02.202618245,000024.02.20260-25.02.202619346,746626.02.202623045,990927.02.202624745,9664 Aktsiaselts Infortar is acquiring its own shares based on the stock exchange announcement . The share buyback programme is managed by SEB Pank AS, which will buy back shares on behalf of Aktsiaselts Infortar. Summary data (daily volume and weigh...
Solvac has taken note of the market reaction following the recent publ...
Solvac has taken note of the market reaction following the recent publication of Syensqo’s results and outlook Press releaseRegulated information Brussels, March 2, 2026, 7.00 am CET Solvac is closely monitoring the situation and is in close contact with Syensqo’s Board of Directors and management. Solvac is fully mobilised in its role as a long‑term reference shareholder and is acting alongside Syensqo to support the company through this phase. Solvac is a public limited company under Belgian law founded in 1983 and listed on the Euronext Brussels stock exchange under the ISIN code BE0...
- Stijn Demeester
Aktsiaseltsi Infortar omaaktsiate omandamise tehingud
Aktsiaseltsi Infortar omaaktsiate omandamise tehingud Aktsiaselts Infortar on perioodil 23 - 27. veebruar 2026 omandanud Nasdaq Tallinna börsil omaaktsiaid alljärgnevalt: KuupäevKoondmaht (tk)Kaalutud keskmine päevahind (EUR)23.02.202618245,000024.02.20260-25.02.202619346,746626.02.202623045,990927.02.202624745,9664 Aktsiaselts Infortar omandab omaaktsiaid vastavalt 20. oktoobril 2025 avalikustatud teatele. Aktsiate tagasiostu täideviijaks ja korraldajaks on AS SEB Pank, kes teostab aktsiate tagasiostu Aktsiaseltsi Infortar nimel. Omandamiste koondandmed (omandatud aktsiate kogus ja kaalut...
Solvac heeft kennisgenomen van de marktreactie op de recente publicati...
Solvac heeft kennisgenomen van de marktreactie op de recente publicatie van de resultaten en vooruitzichten van Syensqo PersberichtGereglementeerde informatie Brussel, 2 maart 2026 – 7u00 CET Solvac volgt de situatie met de grootste aandacht en onderhoudt nauwe contacten met de Raad van Bestuur en het management van Syensqo. Solvac is volledig gemobiliseerd in haar rol als referentieaandeelhouder op lange termijn en handelt samen met Syensqo om de onderneming in deze fase te begeleiden. Solvac is een naamloze vennootschap naar Belgisch recht opgericht in 1983 en genoteerd op Euronext B...
Solvac prend acte de la réaction des marchés à la publication récente ...
Solvac prend acte de la réaction des marchés à la publication récente des résultats et des perspectives de Syensqo Communiqué de PresseInformation réglementée Bruxelles, le 2 mars 2026 – 7h00 CET Solvac suit la situation avec la plus grande attention et est en contact étroit avec le Conseil d’administration et le management de Syensqo. Solvac est pleinement mobilisée dans son rôle d’actionnaire de référence de long terme et agit aux côtés de Syensqo, afin d’accompagner l’entreprise dans cette phase. Solvac est une société anonyme de droit belge fondée en 1983 et ...
- ABGSC Pulp & Paper Research
- Henrik Bartnes
- Martin Melbye
Generation Development Group Limited: 1 director
A director at Generation Development Group Limited maiden bought 30,756 shares at 4.578AUD and the significance rating of the trade was 59/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors ov...
Moody's Ratings assigns A2 rating to Vicinity's Australian Medium Term...
Moody's Ratings (Moody's) has today assigned an A2 senior unsecured rating to the AUD500 million 10-year Australian Medium Term Notes (AMTNs) of Vicinity Centres RE Ltd, a subsidiary of Vicinity Centres (VCX). The notes mature on March 3, 2036. IMPORTANT NOTICE: MOODY'S RATINGS AND P...
- ABGSC Construct. & Real Estate Research
- Fredrik Stensved
- Oscar Lindquist
HUFV A HUFVUDSTADEN AB CLASS A
CAST CASTELLUM AB
CATE CATENA AB
DIOS DIOS FASTIGHETER AB
ATRLJ B ATRIUM LJUNGBERG AB CLASS B
A1W9VK PLATZER FASTIGHETER HOLDING AB CLASS B
STEF B STENDOERREN FASTIGHETER AB CLASS B
POX PANDOX AB CLASS B
A1T7SE AB SAGAX CLASS B
SBB B SAMHALLSBYGGNADSBOLAGET I NORDEN AB CLASS B
FABG FABEGE AB
NYF NYFOSA AB
FAST A FASTPARTNER AB
CIBUS CIBUS NORDIC REAL ESTATE AB
K2A B K2A KNAUST & ANDERSSON FASTIGHETER AB
SFAST STENHUS FASTIGHETER I NORDEN AB
KLARA B KLARABO SVERIGE AB
WIHL WIHLBORG FASTIGHETER AB(PUBL)
BALD B FASTIGHETS AB BALDER
WALL B WALLENSTAM AB
SLP B SWEDISH LOGISTIC PROPERTY AB
EAST-SE EASTNINE
PUBLI PUBLIC PROPERTY INVEST
PRISMA PRISMA PROPERTIES AB
INTEA.B-SE INTEA FASTIGHETER
LOGI A ODD MOLLY INTERNATIONAL AB
- ABGSC Strategy Research
- Bengt Jonassen
Austin Engineering Ltd: 2 directors
Two Directors at Austin Engineering Ltd bought 645,000 shares at between 0.195AUD and 0.200AUD. The significance rating of the trade was 71/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors o...
- ABGSC Healthcare Research
- Morten Larsen
- ABGSC Capital Goods Research
- Anders Idborg
- Karl Bokvist
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.